Almost all of the interactions that were documented with alprazolam are with medicines that modulate CYP3A4 action. Compounds that are inhibitors or inducers of CYP3A would be predicted to raise or lower plasma alprazolam concentrations, respectively. Drug products that have been analyzed in vivo, along with their effect on raising alprazolam AUC, … Read More